pubmed-article:21615918 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0028630 | lld:lifeskim |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0025723 | lld:lifeskim |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0086908 | lld:lifeskim |
pubmed-article:21615918 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:21615918 | pubmed:dateCreated | 2011-6-27 | lld:pubmed |
pubmed-article:21615918 | pubmed:abstractText | The prognosis of cutaneous melanoma (CM) differs for patients with identical clinico-pathological stage, and no molecular markers discriminating the prognosis of stage III individuals have been established. Genome-wide alterations in DNA methylation are a common event in cancer. This study aimed to define the prognostic value of genomic DNA methylation levels in stage III CM patients. | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:language | eng | lld:pubmed |
pubmed-article:21615918 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21615918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21615918 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21615918 | pubmed:issn | 1479-5876 | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:KirkwoodJohn... | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:SigalottiLuca... | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:ColizziFrance... | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:CoralSandraS | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:MaioMicheleM | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:BidoliEttoreE | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:FrattaElisabe... | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:MassarutSamue... | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:CovreAlessiaA | lld:pubmed |
pubmed-article:21615918 | pubmed:author | pubmed-author:ParisiGiuliaG | lld:pubmed |
pubmed-article:21615918 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21615918 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:21615918 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21615918 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21615918 | pubmed:pagination | 78 | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:meshHeading | pubmed-meshheading:21615918... | lld:pubmed |
pubmed-article:21615918 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21615918 | pubmed:articleTitle | Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients. | lld:pubmed |
pubmed-article:21615918 | pubmed:affiliation | Cancer Bioimmunotherapy Unit, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy. | lld:pubmed |
pubmed-article:21615918 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21615918 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |